Clinical validation of a novel quantitative assay for the detection of MGMT methylation in glioblastoma patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-7083
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clinical validation of a novel quantitative assay for the detection of MGMT methylation in glioblastoma patients ; volume:13 ; number:1 ; day:9 ; month:3 ; year:2021 ; pages:1-13 ; date:12.2021
Clinical epigenetics ; 13, Heft 1 (9.3.2021), 1-13, 12.2021
- Creator
-
Rosas-Alonso, Rocio
Colmenarejo-Fernandez, Julian
Pernia, Olga
Rodriguez-Antolín, Carlos
Esteban, Isabel
Ghanem, Ismael
Sanchez-Cabrero, Dario
Losantos-Garcia, Itsaso
Palacios-Zambrano, Sara
Moreno-Bueno, Gema
Castro, Javier de
Martinez-Marin, Virginia
Ibanez-de-Caceres, Inmaculada
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13148-021-01044-2
- URN
-
urn:nbn:de:101:1-2021042820094535555789
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rosas-Alonso, Rocio
- Colmenarejo-Fernandez, Julian
- Pernia, Olga
- Rodriguez-Antolín, Carlos
- Esteban, Isabel
- Ghanem, Ismael
- Sanchez-Cabrero, Dario
- Losantos-Garcia, Itsaso
- Palacios-Zambrano, Sara
- Moreno-Bueno, Gema
- Castro, Javier de
- Martinez-Marin, Virginia
- Ibanez-de-Caceres, Inmaculada
- SpringerLink (Online service)
Other Objects (12)
MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study
Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma
MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma
A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]
Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma
Assessment of MGMT methylation status using high-performance liquid chromatography in newly diagnosed glioblastoma
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
Does positive MGMT methylation outbalance the limitation of subtotal resection in glioblastoma IDH-wildtype patients?
AI tool for predicting MGMT methylation in glioblastoma for clinical decision support in resource limited settings
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients’ survival: a meta-analysis
High density DNA methylation array is a reliable alternative for PCR-based analysis of the MGMT promoter methylation status in glioblastoma
MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study
Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma
MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma
A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]
Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma
Assessment of MGMT methylation status using high-performance liquid chromatography in newly diagnosed glioblastoma
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
Does positive MGMT methylation outbalance the limitation of subtotal resection in glioblastoma IDH-wildtype patients?
AI tool for predicting MGMT methylation in glioblastoma for clinical decision support in resource limited settings
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients’ survival: a meta-analysis
High density DNA methylation array is a reliable alternative for PCR-based analysis of the MGMT promoter methylation status in glioblastoma
MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study
Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma
MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma
A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]
Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma
Assessment of MGMT methylation status using high-performance liquid chromatography in newly diagnosed glioblastoma
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
Does positive MGMT methylation outbalance the limitation of subtotal resection in glioblastoma IDH-wildtype patients?
AI tool for predicting MGMT methylation in glioblastoma for clinical decision support in resource limited settings
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients’ survival: a meta-analysis